Table:
|  |  | Year Ended December 31, |  |  |  |
| --- | --- | --- | --- | --- | --- |
| (In thousands) | 2019 | 2018 | 2017 | 2019 $ Change from 2018 | 2018 $ Change from 2017 |
| Proceeds from sale or issuance of common stock | $0 | $1,283 | $1,568 | $(1,283) | $(285) |
| Taxes paid related to net share settlement of equity awards | (7,286) | (9,466) | (7,269) | 2,180 | (2,197) |
| Proceeds from issuance of 0.875% Convertible Senior Notes | 218,000 | 0 | 0 | 218,000 | 0 |
| Payments for issuance costs on 0.875% Convertible Senior Notes | (5,445) | 0 | 0 | (5,445) | 0 |
| Payments for capped call transaction on 0.875% Convertible Senior Notes | (17,222) | 0 | 0 | (17,222) | 0 |
| Credit facility payments | (220,000) | (713,751) | (138,139) | 493,751 | (575,612) |
| Credit facility borrowings, net of issuance costs | 279,241 | 430,843 | 325,001 | (151,602) | 105,842 |
| Repurchase of common stock | (111,460) | (138,928) | (12,077) | 27,468 | (126,851) |
| Payment of acquisition and other financing obligations | (14,685) | (5,198) | (1,283) | (9,487) | (3,915) |
| Purchases of subsidiary shares owned by non-controlling interest | (53,800) | (7,198) | 0 | (46,602) | (7,198) |
| Net cash provided by (used in) financing activities - continuing operations | 67,343 | (442,415) | 167,801 | 509,758 | (610,216) |
| Net cash provided by (used in) financing activities - discontinued operations | 0 | 149,432 | 30,784 | (149,432) | 118,648 |
| Net cash provided (used in) by financing activities | $67,343 | $(292,983) | $198,585 | $360,326 | $(491,568) |
Paragraphs:
Financing Cash Flow Activities
Year Ended December 31, 2019 Compared with the Year Ended December 31, 2018
Net cash provided by financing activities – continuing operations increased during the year ended December 31, 2019 primarily due to inflows resulting from (i) the issuance of the 0.875% Convertible Senior Notes, (ii) lower credit facility payments, partially offset with less credit facility borrowings and (iii) a decrease in the repurchase of common stock. These were partially offset by the purchase of the remaining minority interest in Pulse8 during 2019.
Year Ended December 31, 2018 Compared with the Year Ended December 31, 2017
We used cash in financing activities – continuing operations during the year ended December 31, 2018 compared with cash inflows from financing activities – continuing operations during the year ended December 31, 2017, which was primarily driven by higher repayments of borrowings outstanding under our senior secured credit facility and higher common stock repurchases. We used a portion of the proceeds from the sale of our investment in Netsmart to repay balances outstanding under our senior secured credit facilities at the end of 2018. We borrowed funds in 2018 to purchase Practice Fusion and Health Grid and to acquire the remaining outstanding minority interest in which we initially acquired a controlling interest in April 2015.
Net cash provided by financing activities – discontinued operations increased during the year ended December 31, 2018 compared with the prior year primarily due to higher borrowings by Netsmart used to finance business acquisitions.
Question:
What is the Proceeds from sale or issuance of common stock in 2018?
Answer: $1,283